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Purpose: Effective treatment of primary subclavian vein thrombosis focuses on restora- 
tion of venous patency, relief of intrinsic stenosis, and decompression of the thoracic 
inlet. The appropriate method and timing for surgery, however, have not been not well 
defined. We conducted a study to determine an acceptable treatment approach. 
Methods: A retrospective r view evaluated 11 patients een at our institution in an 8-year 
period. Seven patients were male and four were female, with an average age of 30 years 
(range 15 to 54 years). Two patients who had symptomatic stenosis without occlusion 
were omitted from the study. All patients with occlusion received urokinase therapy and 
underwent surgical decompression within 5 days of thrombolytic therapy. Five percuta- 
neous transluminal angioplasties were attempted before operative intervention. Eleven 
decompressions were performed, including nine first-rib resections and two scalenec- 
tomies. Five operative venous procedures, consisting of thrombectomy with patch clo- 
sure (n = 3) and bypass (n = 2), and seven venolysis procedures were performed. All 
patients received coumadin for 3 to 6 months after the operation. 
Results: Urokinase therapy established wide venous patency in nine of the 11 extremities 
treated, with the remaining two requiring thrombectomy for residual thrombus at the 
time of operation. One patient who underwent ransluminal angioplasty before the 
operation had rethrombosis, and the remaining four showed no improvement in venous 
stenosis after the intervention. Eight of nine extremities treated by first-rib resection and 
one of two treated by scalenectomy were free of residual symptoms at follow-up. 
Conclusions: Preoperative use of percutaneous balloon angioplasty is ineffective and 
should be avoided in this setting. Surgical intervention within days of thrombolysis 
obviates the need for interim oral anticoagulation a d enables patients to return to nor- 
mal activity sooner. (J Vase Surg 1998;27:1101-8.) 
Primary subclavian vein thrombosis i a patholog- 
ic entity that typically affects young, otherwise 
healthy persons. Definition of the appropriate treat- 
ment regimen has been in evolution since the first 
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description of this disease process by both Paget and 
yon Schroetter more than 100 years ago. Upper 
extremity thrombosis accounts for only 1% to 2% of 
cases of deep venous thromboses, 1 but most of  these 
patients will have long-term disabilities if treatment is
inadequate. Initially, conservative measures, includ- 
ing arm rest, elevation, and anticoagulation, were 
tried in an attempt o allow spontaneous recanaliza- 
tion of the thrombosed vein and subsequent resolu- 
tion of symptoms. However, it is clear that such a 
conservative approach results in significant long-term 
disability, with approximately 75% of patients having 
residual symptoms at follow-up 2 and as many as 12% 
demonstrating pulmonary embolism. 3 
Significant efforts have been made to improve the 
outcome of this disabling disease. Successful treat- 
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ment incorporates a three-pronged approach aimed 
at restoring venous patency, relieving intrinsic venous 
stenosis, and decompressing the thoracic inlet 
around the vein. Catheter-directed thrombolysis has 
been successful in restoring venous patency in a num- 
ber of studies. 4-6 In addition, the recognition that 
anatomic abnormalities in the thoracic inlet con- 
tribute to the pathogenesis of this disease has secured 
a role for operative intervention i its treatment. 
However, the approach to operative decompres- 
sion and the timing of such intervention remain 
unclear. This study reviewed our institutional series, 
and we propose an acceptable treatment approach 
on the basis of our results. 
PATIENTS AND METHODS 
Patient population. The cases of all patients 
who received treatment for venous thrombosis from 
thoracic inlet obstructive disease at the Brigham and 
Women's Hospital between 1988 and 1996 were 
retrospectively reviewed. Hospital charts and opera- 
rive records revealed the demographic features, pre- 
senting symptoms, and treatment approach in each 
case. All patients underwent venography of the 
extremity with symptoms. 
Thrombolyt ic therapy. The brachial vein was 
accessed for venography, with an infusion catheter 
inserted for catheter-directed thrombolysis. By 
means of the pulse-spray method, 125,000 to 
250,000 U urokinase was administered as a bolus. 
Infusion was then continued at a variable rate from 
120,000 to 240,000 U/hr  for 4 hours and general- 
ly at 60,000 U/hr  thereafter. Interval venography 
was performed to assess the efficacy of thrombolysis. 
The urokinase was continued until dissolution of the 
obstructing thrombus was achieved or thrombolysis 
was deemed ineffective. In addition, heparin was 
instituted as a 5000 U bolus followed by a 1000 
U/hr  infusion, with rates adjusted to maintain the 
partial thromboplastin time between 60 and 80 sec- 
onds. Patients were monitored in an intensive care 
unit setting while receiving thrombolytic therapy. 
Operative approach. Operative decompression 
was performed within 5 days ofthrombolysis, main- 
taining full heparin anticoagulation during the pre- 
operative interval after thrombolysis. Surgical inter- 
vention was approached as an exploration to assess 
the status of the involved vein and the anatomy of 
the thoracic inlet. Supraclavicular incisions were 
used in seven operations. We prefer this approach 
because it offers the advantage of access to the jugu- 
lar vein for a turndown bypass if needed and allows 
complete release of adventitial tissue surrounding 
the proximal subclavian vein at he juncture with t e 
innominate. A concurrent infraclavicular incision 
("paraclavicular pproach") was used in one case for 
access to the more distal vein as it coursed beneath 
the clavicle. The paraclavicular strategy has been pre- 
viously described by Thompson et al. 7 Three 
transaxillary approaches to the first rib were also per- 
formed earlier in our series. 
In most situations a partial first-rib resection was 
performed for thoracic inlet decompression through 
a supraclavicular incision. The rib was removed ante- 
riorly, including approximately 1 cm of the costal car- 
tilage and incorporating a segment of rib that 
extended laterally as much as 3 to 4 cm in length. 
The anterior scalene muscle was released from the 
first rib in the process. In cases in which obvious 
bony abnormalities were noted, including prominent 
first-rib tuberosities and clavicular exostoses, the 
offending bony prominences were removed, either 
with the first rib during the resection or by rongeur 
or rotating air bur of the clavicular prominences. 
Anterior scalenectomy without rib resection was 
performed in two cases in which the anterior scalene 
was noted to be markedly hypertrophied and 
appeared to cause significant compression of the 
subclavian vein. The anterior scalene muscle was 
removed in its entirety from the insertion on the first 
rib to the origin on the transverse cervical processes. 
Excision, rather than mere division, of the muscle 
was performed to prevent scar tissue around the sca- 
lene remnant from causing recurrent obstructive 
symptoms. No particular bony abnormalities were 
seen in these instances. 
Fol low-up. All patients were treated with 
coumadin for 3 to 6 months after the operation. 
Follow-up ranged from 6 months to 5 years with a 
mean follow-up of 2 years. Duplex ultrasonography 
was performed on five of the 11 extremities from 1 
to 6 months after the operation to assess patency of 
the subclavian vein. One patient underwent venog- 
raphy 4 months after decompression. Written and 
telephone surveys were conducted with all patients, 
with a 70% response rate. Patients were asked to rate 
the results of their surgery as excellent (no residual 
symptoms), good (minimal residual symptoms with 
no limitation in activity), satisfactory (residual symp- 
toms causing some limitation in activity), or poor 
(persistent symptoms affecting lifestyle). Clinic 
charts were reviewed to supplement follow-up data. 
RESULTS 
Patient presentation. Eleven patients were s en 
at our institution during the 8-year period. Seven 
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were male and four were female, with an average age 
of 30 years (range 15 to 54 years). Eight patients 
had engaged in physical activity involving the affect- 
ed extremity and three could not recall any inciting 
event. No patient had a history of recent catheteri- 
zation or direct rauma to the affected extremity. Of 
the 11 patients een, six had treatment initiated at an 
outside institution for documented subclavian vein 
occlusion. All had received catheter-directed hrom- 
bolysis, with percutaneous balloon angioplasty 
attempted in two cases. 
Restoration of patency. Eleven patients under- 
went urokinase therapy for subclavian vein throm- 
bosis. Thrombolytic therapy was initiated 24 hours 
to 21/2 weeks after symptom onset, depending on the 
timing of patient presentation and diagnosis. Most 
patients began thrombolytic therapy within 72 
hours of symptom onset. Thrombolysis was contin- 
ued until the vein appeared free of intraluminal 
defects on venography with no partial filling defects 
or eccentric irregularities noted. Urokinase therapy 
restored venous patency in nine extremities treated, 
with the remaining two requiring supplemental 
thrombectomy for residual thrombus at the time of 
operation. Venotomies were closed with a saphenous 
vein patch in both cases. No complications of 
thrombolytic therapy were encountered. After 
thrombolysis, 10 extremities demonstrated a fixed, 
focal stenosis of the subclavian vein. One patient had 
a dynamic occlusion, with abduction of the affected 
arm. In most cases the stenosis noted on venography 
was the result of extrinsic ompression. In the three 
cases in which the vein was opened, fresh clot, old 
clot, and intraluminal plugs of scar tissue were all 
retrieved. 
Relief of  venous stenosis. Five percutaneous 
transluminal ngioplasties (PTAs) were performed 
before the operation at the discretion of the angiog- 
rapher and primary surgeon when thrombolysis 
revealed an underlying, flow-restricting stenosis. 
One patient who underwent PTA had rethrombosis, 
necessitating surgical thrombectomy after a second 
attempt at thrombolysis. This patient was found at 
the time of operation to have an intimal injury, 
which was presumed to have been caused by the 
angioplasty. In the remaining four cases no signifi- 
cant improvement in the degree of venous tenosis 
was obtained with angioplasty. 
Circumferential release of thickened adventitial 
tissue ("venolysis"), as described by Thompson et 
al.,7 was performed in seven cases when the vein was 
found to be encased in surrounding scar tissue. 
Venolysis appeared to relieve venous tenosis in four 
cases, with no further venous surgery required. In 
the remaining three instances, two patch angioplas- 
ties and one venous bypass were performed. In total, 
five operative venous procedures, including throm- 
boendarterectomy with patch closure (n = 3) and 
bypass (n = 2), were performed in our series. 
Two venous bypasses were constructed for areas 
of chronic narrowing and thickening that did not 
appear amenable to direct repair. In one situation 
venolysis was attempted but was unsuccessful in
relieving the stenosis. In the other case the vein was 
judged uncorrectable after direct palpation and 
assessment ofthe stenotic region. One of the bypass- 
es was performed in conjunction with scalenectomy; 
the second was required at reoperation for rethrom- 
bosis 5 days after first-rib resection. A turn-down 
jugular vein-subclavian vein bypass was constructed 
for both patients. One bypass remains patent accord- 
ing to postoperative ultrasonography. The remaining 
graft has not been assessed objectively, but the 
patient remains ymptom free. 
Decompression of thoracic inlet. Eleven 
decompressions, ine partial first-rib resections and 
two isolated scalenectomies, were performed. Most 
patients underwent bony decompression f the tho- 
racic inlet. In two situations, however, the anterior 
scalene muscle was noted to be markedly hypertro- 
phied and appeared to cause significant extrinsic 
compression of the vein. In one instance the vein 
also appeared to be chronically scarred and thick- 
ened, and direct repair was deemed inappropriate. A 
bypass was therefore performed without further 
bony decompression. I  the second case the vein 
appeared to be soft, with no appreciable scarring. 
Removal of the scalene muscle appeared to suffi- 
ciently release the extrinsic ompression on the vein. 
These two cases represent instances in our series in 
which muscular decompression without bony resec- 
tion was performed. 
Of the patients who underwent partial first-rib 
resection, eight are currently symptom free at fol- 
low-up. The remaining patient reports a "sense of 
some residual inflammatory scar tissue, but no dis- 
comfort or swelling." Of the two patients who 
underwent isolated scalenectomy, one is symptom 
free and the other has some limitation in activity 
with the affected extremity. 
Rethrombosis necessitating further intervention 
developed in two patients, one within 5 days and the 
other within 4 weeks of partial first-rib resection. 
Both patients had been maintained on a regimen of 
oral coumadin. One patient required athrombecto- 
my and patch closure (with a segment of external 
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jugular vein) with completion of the first-rib resec- 
tion; the other required a jugular vein-subclavian 
vein bypass. 
DISCUSSION 
Effective treatment of primary subclavian vein 
thrombosis addresses thc three pathologic phases 
underlying this disease: (1) venous occlusion, (2) 
intrinsic venous stenosis, and (3) extrinsic venous 
compression. For restoration of  patency, studies 
comparing conventional anticoagulation with 
thrombolytic therapy demonstrate that catheter- 
directed thrombolysis is more effective, s In our 
series urokinase therapy eliminated all significant 
clot with restoration of venous patency in nine of 11 
patients, with the other two requiring supplemental 
thrombectomy for residual thrombus at the time of 
the operation. No complications of thrombolytic 
therapy were encountered. It is generally well 
accepted that catheter-directed thrombolysis is safe 
and effective in restoring venous patency and should 
be implemented, barring any contraindications, on
diagnosis of primary subclavian vein thrombosis. 
No clear association between duration of symp- 
toms and success of thrombolytic therapy was seen. 
Although most patients with subclavian vein occlu- 
sion received thrombolysis within 72 hours of symp- 
tom onset, one patient underwent successful disso- 
lution of thrombus with urokinase after 21/2 weeks. 
Others have reported that thromboses as old as 3 
weeks have been amenable to successful lysis. 8 On 
the other hand, two of our patients who received 
thrombolysis after a few days had only partial suc- 
cess. No clear determinants of thrombolytic success 
have been identified, although most advocate insti- 
tution ofthrombolysis a soon as possible, preferably 
within 7 days, s to increase the probability of suc- 
cessful dissolution. 
With elimination of all thrombus and restoration 
of patency, many patients are found to have a fixed 
stenosis of the subclavian vein at the juncture of the 
clavicle and the first rib. Several methods for cor- 
recting intrinsic stenosis have been suggested, 
including venolysis, patch angioplasty, bypass of the 
stenotic segment, and PTA with stent placement. As 
reported by Thompson et al., 7 we found that a sig- 
nificant number of patients had dense scar tissue sur- 
rounding the vein, causing afixed stenosis. Vcnolysis 
was therefore performed in seven cases, in an 
attempt to release the vein from the fibrous encasc- 
ment. In four cases venolysis was sufficient to relieve 
venous stenosis. The veins were rendered soft and 
pliable, with no evidence of significant flow distur- 
bance seen on intraoperative Doppler ultrasonogra- 
phy. Direct palpation and insufflation of the vein 
with respiration can be used for gross assessment of
the status of the vein. Intraoperative Doppler ultra- 
sonography may be useful for assessing flow distur- 
bances within the lumen, and venography may be 
beneficial for demonstrating persistent luminal nar- 
rowing suggestive of residual scar tissue or webs. 
Veins were opened and directly explored in two 
instances in which venolysis alone did not appear to 
relieve stenosis ufficiently. Fresh clot, as well as old 
thrombus and postphlebitic web and scarring, were 
found. Endarterectomy, web resection, and patch 
closure were performed. Bypass was required in the 
remaining case. 
In total, two patients in our series required bypass 
for areas of stenosis that did not appear amenable to 
direct repair. For both reconstructions jugular 
vein-subclavian vein bypasses were performed 
through the original supraclavicular incision. The 
internal jugular vein was turned down and anasto- 
mosed to the subclavian vein in an end-to-side fash- 
ion. Other types of bypasses have been described, 
including bypass of the internal jugular vein to the 
axillary vein 9 and of the external jugular vein to the 
subclavian vein with a saphenous vein graft, l° In gen- 
eral, although abypass involves amore extensive pro- 
cedure, it may be necessary in some situations to 
establish adequate venous outflow for the upper 
extremity. Arteriovenous fistulas were not used to 
maintain venovenous bypass patency in our patients. 
On follow-up, patients who underwent bypass 
remain symptom free, with one graft remaining 
patent on postoperative ultrasonography. 
Although five preoperative PTAs were per- 
formed in our series, it is not surprising that PTA 
was ineffective in relieving stenosis before extrinsic 
muscular and bony decompression. Although we did 
not observe an increased rate of rethrombosis with 
PTA, one of our patients did have a subadventitial 
hematoma that resulted from an intimal tear; this 
was repaired with venotomy and saphenous vein 
patch angioplasty. Machleder lI reports poor efficacy 
of preoperative PTA, with the failure of this proce- 
dure correlating significantly and adversely with 
long-term patency rates. Also, he has noted no addi- 
tive long-term patcncy with PTA versus thrombolyt- 
ic therapy alone. Unless the extrinsic omponent is
released surgically, PTA will have no durable role 
and should be reserved for possible use in situations 
in which postoperative venography demonstrates 
residual intrinsic stenosis. 
Venous stents have recently been introduced as a 
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possible alternative method to maintain luminal 
diameter with PTA. Meier et al.12 performed a ret- 
rospective case review in which 11 patients who 
underwent stent placement were studied. They con- 
cluded that stent placement should always be 
accompanied by first-rib resection, unless precluded 
by significant rethrombosis. Bjarnason et al. 13 
reported acase in which a Palmaz stent placed across 
a region of significant venous stenosis before tho- 
racic inlet decompression was noted to collapse, with 
occlusion of the lumen. Long-term results regarding 
the use of stents for upper extremity venous tenosis 
are lacldng, and concerns regarding stent fracturing 
and adverse intimal reactions have yet to be 
addressed. 
Several methods for decompressing the thoracic 
inlet have been reported, involving removal of bony 
or musculofascial e ements. 14-16 First-rib resection 
appears to be the favored method of surgical decom- 
pression.14, 16 Isolated scalenectomy was performed 
in two of our patients who demonstrated signifi- 
cantly hypertrophied scalene muscles that appeared 
to cause external compression of the subclavian vein. 
One patient who underwent scalenectomy with 
bypass of the chronically strictured segment is symp- 
tom free; the other has minimal residual symptoms, 
with some limitation of activity on follow-up. 
Although our experience is limited, it appears that 
extrinsic decompression with scalenectomy alone 
may not be an adequate method of inlet decompres- 
sion, even though the scalene muscle may appear to 
be significantly hypertrophied on intraoperative 
assessment. 
The optimal timing of surgical decompression 
remains unresolved. In an effort to avoid early 
rcthrombosis, Machleder and others H recommend 
delaying surgery for 3 months after thrombolysis to 
allow healing of the venous endothelium and resolu- 
tion of the acute, presenting process. This approach 
is based on experience with lower extremity venous 
thrombosis. With thoracic inlet occlusive disease, 
however, an underlying anatomic abnormality per- 
sists, and this places the patient at risk for rethrom- 
bosis during the 3-month interval. Machleder n wit- 
nessed a 10% rethrombosis rate during the period of 
anticoagulation. I  this group of primarily oung and 
active persons, the delay also represcnts a period of 
incapacitation for most patients, who continue to 
have symptoms during that time. At the end of the 3- 
month period of anticoagulation, 72% of patients in 
Kunkel and Machleder's tudyt7 had residual symp- 
toms that restricted them from their usual occupa- 
tion or activities. Whether specifically instructed to 
limit activity level or not, most patients were rcstrict- 
ed by their persistent symptoms. 
We and others 18, 19 prefer to perform operative 
decompression during the initial hospitalization 
after thrombolysis. We believe that the risk for 
rethrombosis is not increased by early operation and 
theorize that it may in fact be reduced by early cor- 
rection of the underlying anatomic abnormalities. In
our series, two patients (12.5%) had rethrombosis 
after the operation, but neither rethrombosis 
appears to be a consequence of early operation. In 
one situation a completion of the first-rib resection 
was required because adequate decompression had 
not been accomplished initially. In the second case a 
bypass was required for a chronically stenotic intrin- 
sic vein segment hat perhaps should have been 
bypassed initially, rather than patched open. Our 
instances of rethrombosis seem to be the result of 
ineffective original decompression, rather than of 
early surgical manipulation. On follow-up 10 of the 
11 extremities operated on (90%) are symptom free 
or show minimal symptoms after surgical repair. 
Although anatomic follow-up with ultrasonography 
was incomplete, no late occlusions are known to 
have occurred. Urschel and Razzuk is report similar 
results, with 89% of their patients returning to work 
free of symptoms after thrombolysis and immediate 
surgical decompression. Molina 19 also advocates 
immediate surgical decompression. All patients in 
his series who were treated with thrombolysis and 
early operative intervention for acute thrombosis 
demonstrated patent veins of adequate caliber on 
follow-up. On the basis of these studies and our 
results, an intervening period of anticoagulation 
before operative repair does not appear to be neces- 
sary and only delays return to activity for these 
young and otherwise active individuals. 
The patients in this series comprise a subset of 
individuals who are first seen specifically with venous 
compression at the thoracic inlet. We caution that 
patients with venous disease should be considered 
separately from the group with the broader diagno- 
sis of"thoracic outlet syndrome," which encompass- 
es individuals with neurologic symptoms as well. As 
both Machleder ll and Molina 20 have recognized, 
this distinction is important because the former 
group is less likely to respond to first-rib resection 
and scalenectomy alone, which has previously been 
described for thoracic outlet syndrome, 21 and 
requires a multimodal approach for durable and 
effective treatment. Table I summarizes the tailored 
treatment regimens applied to each patient in our 
series and the results of such therapy. 
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Table I. Tailored treatment for subclavian vein thrombosis 
Case Restoration of flow Operative approach Relief of stenosis Inlet decompression Results 
1 Urokinase Paraclavicular Venolysis 
2 Urokinase, Supraclavicular Venolysis, patch 
thrombectomy 
3 Urokinase, thromb- Supraclavicular Patch closure 
ectomy 
3* Supraclavicular IJ-SCV bypass 
4 Urokinase Supraclavicular 
5 Urokinasc Transaxillary 
5" Urokinase, thromb- Infraclavicular 
ectomy 
6 Urokinase Transaxillary 
7 Urokinase Supraclavicular 
8 Urokinase TransaxiUary 




10 Urokinase Supraclavicular Venolysis 
11 Uroldnase Supraclavicular Venolysis, IJ- 
SCV bypass 
1st rib resection "Excellent" venogram 
showing no clot 
1st rib resection, air 
bur of costal and "Excellent" ultrasonography 
clavicular prominences showing no clot 
1st rib resection Ultrasonography showing 
Rongeur of clavicular 
exostoses 
1st rib resection with 
removal of promi- 
nence costal tuberosity 
1st rib resection 
Completion of rib 
resection 
1st rib resection 
1st rib resection 
1st rib resection 
1st rib resection with 










graphy showing no clot 
"Excellent" ultrasonography 
showing no clot 
&symptomatic 
Asymptomatic; ultrasono- 
graphy showing no clot 
Asymptomafic 
Persistent symptoms with 
some activity limit 
"Excellent" 
IJ-SCV, Internal jugular vein-subclavian vein. 
*Reoperation. 
The findings of this study support existing 
data18, 19 that early operative intervention is a safe 
and effective treatment approach after catheter- 
directed thrombolytic therapy for primary subcla- 
vian vein thrombosis. In addition, PTA and stent 
placement appear to have no durable role in the pre- 
operative period. Operative decompression should 
be planned as an exploration, with the goal of reliev- 
ing all elements that are found to contribute to 
extrinsic venous compression. We prefer a supraclav- 
icular approach, supplemented by an infraclavicular 
counterincision when necessary, for this exploration. 
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DISCUSSION 
Dr. Jonathan P. Gertler (Boston, Mass.). I agree com- 
pletely with your bias that early intervention for this 
process is better. I think patients are limited. If you delay 
for 3 months, there is at least the chance for rethrombo- 
sis. I have a comment and some questions in terms of 
management schemes. 
First, many patients with upper extremity thrombosis 
who undergo conservative thcrapy will go on to have no 
symptoms because of collateralization. You mentioned that 
one of your patients had a duplex confirmation of patency 
of a jugular turndown. I would be anxious to see whether 
there is opportunity to follow-up the rest of the patients 
more closely. Talking to many patients by phone or having 
written surveys implies no symptoms and implies patency. 
Yet, I still think that there may be a higher rethrombosis 
rate with adequate collateralization a d that you are in fact 
missing the natural history even with decompression i  
many of these patients. I am curious about the role of 
angioplasty. Authors have recommended angioplasty fol- 
lowed by thoracic outlet decompression. I  my experience, 
we get to the operating room and find that indeed the 
venous tract is again rethrombosed postangioplasty, and we 
start the process all over again. Yet, decompression initial- 
ly with heparin umbrella nd subsequent angioplasty may 
open the vein, avoid the difficulty of exposure with a 
venous endarterectomy and patch or venous bypass, and 
allow an angioplasty after the decompression, which then is 
long lasting because the repetitive trauma is removed. I 
wonder if you might comment on that. 
My other question follows from this. Do you think 
there is any role for stents in this? 
Dr. Maggie C. Lee. I will first address the third ques- 
tion. We did not use any stents in our study. In 1996, 
Meier from Yale University did a retrospective r view of 
11 patients who were treated for this disease. Of those 
patients, eight received wall stents (the flexible stents ver- 
sus the fixed stents), and of those eight patients, four 
received subsequent surgical decompression. Two 
patients were offered decompression and refused. Their 
stents actually fractured without the extrinsic decompres- 
sion. Although they remained patent, they were fractured. 
The remaining two were not offered decompression a d 
had rethrombosed. 
What the role of stents will be in this situation is diffi- 
cult to determine. Preliminary results do not seem encour- 
aging, although Meier does recommend that, before 
extrinsic decompression, stents should have no role. We 
agree with this. The authors also recommend that, after 
surgery, there possibly could be a role for stents after an 
attempt at percutaneous transhiminal ngioplasty. If  there 
is still a greater than 50% residual stenosis after PTA, then, 
in that situation, you can consider stenting. It is difficult 
to know the long-term results of a stent in place and a 
fractured but patent stent in place, and it is difficult to 
know the effects on the intima and whether or not those 
will have long-term patency. 
Dr. J. Dennis Baker (Los Angeles, Calif.). I would like 
to represent the often-quoted UCLA experience. 
First of all, I would like to echo what was just said by 
the previous discussant about the importance of getting 
directive follow-up. Many patients who are lysed will 
develop recurrent hrombosis, which is, if not totally 
asymptomatic, sufficiently less symptomatic that they do 
not consider that they have returned to where they start- 
ed. In Dr. Machleder's study, most patients had follow-up 
venograms. 
In our initial cases, when decompressive procedures 
were done early after lyric therapy, there was an amazing 
amount of reaction around the vein. This led Dr. 
Machleder to the more conservative approach of doing 
the lysis, anticoagulating the patient with coumadin, and 
waiting 6 to 8 weeks to do the decompression, which was 
usually a first rib or cervical and first rib resection through 
the transaxillary approach. 
We have done few open procedures on the vein. After 
thoracic outlet decompression, balloon angioplasty is used 
for residual stenosis. In our experience, almost every sin- 
gle case has responded well to balloon angioplasty once 
there is a fully decompressed thoracic outlet. Thus, we 
have not used stents, and we have only had 2 or 3 cases 
that have required irect attack on the vein. 
Many of these patients will remain symptomatic even 
when they have a perfectly normal vein. So, you should 
not judge by symptoms in the early postoperative or post- 
lysis course because the patient has much residual swelling 
and soreness. These patients hould not return to heavy 
labor work immediately. Some of these patients have resid- 
ual problems, and some of the rethromboses that occur 
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after the decompression may be related to excessive arly 
use of the arm while there is still much local swelling. 
Dr. Lee. I agree with the comments regarding the 
angioplasty. Before extrinsic decompression, there is no 
role for any kind of intervention, whether it be percuta- 
neous transluminal ngioplasty or stent. It makes no sense 
theoretically if there is still an extrinsic component com- 
pressing on the vein. To try to intervene in that situation 
may be futile and may actually result in longer term mor- 
bidity rates of rethrombosis and such. 
In terms of the timing of surgery, obviously the issue 
is controversial. In our institution, we are comfortable that 
we have not had the results of an increased rate of  
rethrombosis, although we have not objectively studied 
every extremity that was surgically connected. Of those 
that were studied, the 10 ultrasounds and venograms 
showed patent vein. Although the remaining 6 were not 
objectively studied and they are asymptomatic, they may 
be rethrombosed or they may even be stenotic still. 
Dr. Nancy L. Cantelmo (Boston, Mass.). Would you 
clarify your surgical recommendation for me? I was not 
clear about what you were saying. Would you say that 
scalenotomy or scalenectomy alone was not adequate? 
Would you always recommend a bony resection compo- 
nent to your therapy? 
Dr. Lee. When you approach this surgically, you should 
have the idea that this is an exploration. You also should 
have in mind the three particular components that con- 
tribute to this disease. You should systematically address 
each one and be stuce that you are happy with your results 
of the vein patency, the intrinsic stenosis, and such. 
Although this is a small cohort and a select situation, a few 
of the patients in this study did have reasonable success 
with scalenectomy alone. In those cases, if the patients had 
had some lement of bony decompression in the operating 
room, then assuredly they would not have stopped at just 
a scalenectomy. There would have been greater decom- 
pression and the removal of whatever bony elements were 
involved or even the first rib. So, I would not say that you 
could not do it, but you should have in mind that the goal 
should be to relieve all the constricting components. This 
may require something different in each individual case. 
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